{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:51:47Z","timestamp":1789663907744,"version":"4.0.1"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T00:00:00Z","timestamp":1712534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Doctoral Research Initiation Fund of the Affiliated Hospital of Southwest Medical University","award":["19071"],"award-info":[{"award-number":["19071"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>We conducted a Mendelian randomization (MR) study to elucidate the anti-infective effects of ticagrelor.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Single-nucleotide polymorphisms (SNPs) associated with serum levels of ticagrelor or its major metabolite AR-C124910XX (ARC) in the Platelet Inhibition and Patient Outcomes trial were selected as genetic proxies for ticagrelor exposure. Positive control analyses indicated that genetically surrogated serum ticagrelor levels (6 SNPs) but not ARC levels (2 SNPs) were significantly associated with lower risks of coronary heart disease. Therefore, the 6 SNPs were used as genetic instruments for ticagrelor exposure, and the genome-wide association study data for 5 infection outcomes were derived from the UK Biobank and FinnGen consortium.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The 2-sample MR analyses based on inverse variance\u2013weighted methods indicated that genetic liability to ticagrelor exposure could reduce the risk of bacterial pneumonia (odds ratio, 0.82; 95% CI, .71\u2013.95; P = 8.75E-03) and sepsis (odds ratio, 0.83; 95% CI, .73\u2013.94; P = 3.69E-03); however, no causal relationship was detected between ticagrelor exposure and upper respiratory infection, pneumonia, and urinary tract infection. Extensive sensitivity analyses corroborated these findings.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Our MR study provides further evidence for the preventive effects of ticagrelor on bacterial pneumonia and sepsis.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/infdis\/jiae177","type":"journal-article","created":{"date-parts":[[2024,4,4]],"date-time":"2024-04-04T23:36:48Z","timestamp":1712273808000},"page":"e583-e589","source":"Crossref","is-referenced-by-count":3,"title":["Associations Between Ticagrelor Use and the Risk of Infections: A Mendelian Randomization Study"],"prefix":"10.1093","volume":"231","author":[{"given":"Meng","family":"Xia","sequence":"first","affiliation":[{"name":"Department of Cardiology, The Affiliated Hospital of Southwest Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingmeng","family":"Wu","sequence":"additional","affiliation":[{"name":"Healthcare-Associated Infections Control Center, The Affiliated Chinese Medicine Hospital of Southwest Medical University , Luzhou"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Longchang People's Hospital , Neijiang ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongquan","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Affiliated Hospital of Southwest Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4486-4284","authenticated-orcid":false,"given":"Cheng","family":"Qian","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Affiliated Hospital of Southwest Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,4,8]]},"reference":[{"key":"2025031709164673100_jiae177-B1","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2025031709164673100_jiae177-B2","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jacc.2016.03.513","article-title":"2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"68","author":"Levine","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2025031709164673100_jiae177-B3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/eurheartj\/ehx419","article-title":"2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the Task Force for Dual Antiplatelet Therapy in Coronary Artery Disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-thoracic Surgery (EACTS)","volume":"39","author":"Valgimigli","year":"2018","journal-title":"Eur Heart J"},{"key":"2025031709164673100_jiae177-B4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur Heart J"},{"key":"2025031709164673100_jiae177-B5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.tips.2021.10.010","article-title":"Adenosine and inflammation: it's time to (re)solve the problem","volume":"43","author":"Antonioli","year":"2022","journal-title":"Trends Pharmacol Sci"},{"key":"2025031709164673100_jiae177-B6","doi-asserted-by":"crossref","first-page":"517","DOI":"10.3109\/09537104.2013.842965","article-title":"Lower mortality following pulmonary adverse events and sepsis with ticagrelor compared to clopidogrel in the PLATO study","volume":"25","author":"Storey","year":"2014","journal-title":"Platelets"},{"key":"2025031709164673100_jiae177-B7","doi-asserted-by":"crossref","first-page":"106752","DOI":"10.1016\/j.ijantimicag.2023.106752","article-title":"Propensity-matched analysis of the protective effect of ticagrelor versus clopidogrel on the risk of developing Staphylococcus aureus bacteremia","volume":"61","author":"Gentry","year":"2023","journal-title":"Int J Antimicrob Agents"},{"key":"2025031709164673100_jiae177-B8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.atherosclerosis.2021.06.924","article-title":"Ticagrelor and the risk of infections during hospitalization in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention","volume":"331","author":"Lian","year":"2021","journal-title":"Atherosclerosis"},{"key":"2025031709164673100_jiae177-B9","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jhin.2019.09.018","article-title":"Infectious complications in patients receiving ticagrelor or clopidogrel before coronary artery bypass grafting","volume":"104","author":"Dalen","year":"2020","journal-title":"J Hosp Infect"},{"key":"2025031709164673100_jiae177-B10","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.jcin.2012.03.018","article-title":"Serious infection after acute myocardial infarction: incidence, clinical features, and outcomes","volume":"5","author":"Truffa","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"key":"2025031709164673100_jiae177-B11","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s43586-021-00092-5","article-title":"Mendelian randomization","volume":"2","author":"Sanderson","year":"2022","journal-title":"Nat Rev Methods Primers"},{"key":"2025031709164673100_jiae177-B12","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/sim.3034","article-title":"Mendelian randomization: using genes as instruments for making causal inferences in epidemiology","volume":"27","author":"Lawlor","year":"2008","journal-title":"Stat Med"},{"key":"2025031709164673100_jiae177-B13","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1001\/jama.2021.18236","article-title":"Strengthening the reporting of observational studies in epidemiology using mendelian randomization: the STROBE-MR statement","volume":"326","author":"Skrivankova","year":"2021","journal-title":"JAMA"},{"key":"2025031709164673100_jiae177-B14","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1093\/eurheartj\/ehv116","article-title":"Effect of genetic variations on ticagrelor plasma levels and clinical outcomes","volume":"36","author":"Varenhorst","year":"2015","journal-title":"Eur Heart J"},{"key":"2025031709164673100_jiae177-B15","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1093\/bioinformatics\/btv402","article-title":"LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants","volume":"31","author":"Machiela","year":"2015","journal-title":"Bioinformatics"},{"key":"2025031709164673100_jiae177-B16","volume-title":"Applied biopharmaceutics and pharmacokinetics","author":"Shargel","year":"2012","edition":"6th ed"},{"key":"2025031709164673100_jiae177-B17","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/s41588-020-0622-5","article-title":"Exploring and visualizing large-scale genetic associations by using PheWeb","volume":"52","author":"Gagliano Taliun","year":"2020","journal-title":"Nat Genet"},{"key":"2025031709164673100_jiae177-B18","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"key":"2025031709164673100_jiae177-B19","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/CIRCRESAHA.117.312086","article-title":"Identification of 64 novel genetic loci provides an expanded view on the genetic architecture of coronary artery disease","volume":"122","author":"van der Harst","year":"2018","journal-title":"Circ Res"},{"key":"2025031709164673100_jiae177-B20","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/eurheartj\/ehaa1040","article-title":"Genome-wide analysis identifies novel susceptibility loci for myocardial infarction","volume":"42","author":"Hartiala","year":"2021","journal-title":"Eur Heart J"},{"key":"2025031709164673100_jiae177-B21","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/gepi.21758","article-title":"Mendelian randomization analysis with multiple genetic variants using summarized data","volume":"37","author":"Burgess","year":"2013","journal-title":"Genet Epidemiol"},{"key":"2025031709164673100_jiae177-B22","doi-asserted-by":"crossref","first-page":"e1007081","DOI":"10.1371\/journal.pgen.1007081","article-title":"Orienting the causal relationship between imprecisely measured traits using GWAS summary data","volume":"13","author":"Hemani","year":"2017","journal-title":"PLoS Genet"},{"key":"2025031709164673100_jiae177-B23","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"key":"2025031709164673100_jiae177-B24","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1093\/bioinformatics\/btz469","article-title":"PhenoScanner V2: an expanded tool for searching human genotype-phenotype associations","volume":"35","author":"Kamat","year":"2019","journal-title":"Bioinformatics"},{"key":"2025031709164673100_jiae177-B25","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from mendelian randomization between complex traits and diseases","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"2025031709164673100_jiae177-B26","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/gepi.21965","article-title":"Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator","volume":"40","author":"Bowden","year":"2016","journal-title":"Genet Epidemiol"},{"key":"2025031709164673100_jiae177-B27","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.smim.2016.10.005","article-title":"Platelets and infection","volume":"28","author":"Deppermann","year":"2016","journal-title":"Semin Immunol"},{"key":"2025031709164673100_jiae177-B28","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11239-012-0833-4","article-title":"Clopidogrel treatment and the incidence and severity of community acquired pneumonia in a cohort study and meta-analysis of antiplatelet therapy in pneumonia and critical illness","volume":"35","author":"Gross","year":"2013","journal-title":"J Thromb Thrombolysis"},{"key":"2025031709164673100_jiae177-B29","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1001\/archinternmed.2009.42","article-title":"Aspirin plus clopidogrel and risk of infection after coronary artery bypass surgery","volume":"169","author":"Blasco-Colmenares","year":"2009","journal-title":"Arch Intern Med"},{"key":"2025031709164673100_jiae177-B30","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1007\/s43440-021-00309-0","article-title":"A review of the effects of ticagrelor on adenosine concentration and its clinical significance","volume":"73","author":"Akkaif","year":"2021","journal-title":"Pharmacol Rep"},{"key":"2025031709164673100_jiae177-B31","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.vph.2015.02.006","article-title":"Ticagrelor potentiates adenosine-induced stimulation of neutrophil chemotaxis and phagocytosis","volume":"71","author":"Alsharif","year":"2015","journal-title":"Vascul Pharmacol"},{"key":"2025031709164673100_jiae177-B32","doi-asserted-by":"crossref","first-page":"eabd6737","DOI":"10.1126\/scitranslmed.abd6737","article-title":"Repurposed drugs block toxin-driven platelet clearance by the hepatic Ashwell-Morell receptor to clear Staphylococcus aureus bacteremia","volume":"13","author":"Sun","year":"2021","journal-title":"Sci Transl Med"},{"key":"2025031709164673100_jiae177-B33","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1001\/jamacardio.2019.1189","article-title":"Antibacterial activity of ticagrelor in conventional antiplatelet dosages against antibiotic-resistant gram-positive bacteria","volume":"4","author":"Lancellotti","year":"2019","journal-title":"JAMA Cardiol"},{"key":"2025031709164673100_jiae177-B34","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/ehjcvp\/pvaa065","article-title":"Risk of infections in patients treated with ticagrelor vs clopidogrel: a systematic review and meta-analysis","volume":"7","author":"Li","year":"2021","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2025031709164673100_jiae177-B35","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/ehjcvp\/pvaa099","article-title":"Ticagrelor and the risk of Staphylococcus aureus bacteraemia and other infections","volume":"8","author":"Butt","year":"2022","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2025031709164673100_jiae177-B36","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4161\/viru.27372","article-title":"Epidemiology of severe sepsis","volume":"5","author":"Mayr","year":"2014","journal-title":"Virulence"},{"key":"2025031709164673100_jiae177-B37","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.amjcard.2020.06.016","article-title":"Effect of ticagrelor on reducing the risk of gram-positive infections in patients with acute coronary syndrome","volume":"130","author":"Lupu","year":"2020","journal-title":"Am J Cardiol"},{"key":"2025031709164673100_jiae177-B38","doi-asserted-by":"crossref","first-page":"112952","DOI":"10.1016\/j.biopha.2022.112952","article-title":"Mendelian randomization in pharmacogenomics: the unforeseen potentials","volume":"150","author":"Khasawneh","year":"2022","journal-title":"Biomed Pharmacother"},{"key":"2025031709164673100_jiae177-B39","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/eurheartj\/ehi754","article-title":"Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin","volume":"27","author":"Husted","year":"2006","journal-title":"Eur Heart J"}],"updated-by":[{"DOI":"10.1093\/infdis\/jiae356","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T00:00:00Z","timestamp":1722902400000},"record-id":"55568"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiae177\/58739390\/jiae177.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/231\/3\/e583\/58739390\/jiae177.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/231\/3\/e583\/58739390\/jiae177.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T09:17:04Z","timestamp":1742203024000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/231\/3\/e583\/7641955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,8]]},"references-count":39,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,4,8]]},"published-print":{"date-parts":[[2025,3,17]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiae177","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,3,15]]},"published":{"date-parts":[[2024,4,8]]}}}